Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $134.48 in the prior trading day, Illumina Inc (NASDAQ: ILMN) closed at $132.75, down -1.29%. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 0.75 million shares were traded. ILMN stock price reached its highest trading level at $134.05 during the session, while it also had its lowest trading level at $132.61.
Ratios:
Our goal is to gain a better understanding of ILMN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.28. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 0.63.
On July 11, 2025, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform but kept the price unchanged to $125.
Citigroup reiterated its Neutral rating for the stock on March 04, 2025, while the target price for the stock was revised from $130 to $90.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 12 ’25 when Davies Scott M sold 323 shares for $136.09 per share. The transaction valued at 43,957 led to the insider holds 17,887 shares of the business.
SCOTT DAVIES bought 323 shares of ILMN for $43,957 on Dec 12 ’25. On Dec 08 ’25, another insider, Wedel Christensen Jakob, who serves as the SVP, Strategy/Corp Development of the company, sold 549 shares for $129.27 each. As a result, the insider received 70,969 and left with 10,952 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ILMN now has a Market Capitalization of 20403675136 and an Enterprise Value of 21582200832. As of this moment, Illumina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.74, and their Forward P/E ratio for the next fiscal year is 26.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.73 while its Price-to-Book (P/B) ratio in mrq is 8.53. Its current Enterprise Value per Revenue stands at 5.033 whereas that against EBITDA is 18.494.
Stock Price History:
The Beta on a monthly basis for ILMN is 1.42, which has changed by 0.027113676 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, ILMN has reached a high of $153.06, while it has fallen to a 52-week low of $68.70. The 50-Day Moving Average of the stock is 8.42%, while the 200-Day Moving Average is calculated to be 34.84%.
Shares Statistics:
The stock has traded on average 1.77M shares per day over the past 3-months and 1652060 shares per day over the last 10 days, according to various share statistics. A total of 153.00M shares are outstanding, with a floating share count of 148.51M. Insiders hold about 2.81% of the company’s shares, while institutions hold 104.25% stake in the company. Shares short for ILMN as of 1765756800 were 7411422 with a Short Ratio of 4.18, compared to 1763078400 on 6544061. Therefore, it implies a Short% of Shares Outstanding of 7411422 and a Short% of Float of 7.57.
Earnings Estimates
At present, 16.0 analysts are actively evaluating the performance of Illumina Inc (ILMN) in the stock market.The consensus estimate for the next quarter is $1.12, with high estimates of $1.21 and low estimates of $0.98.
Analysts are recommending an EPS of between $4.79 and $4.66 for the fiscal current year, implying an average EPS of $4.71. EPS for the following year is $5.01, with 18.0 analysts recommending between $5.19 and $4.58.
Revenue Estimates
15 analysts predict $1.1B in revenue for. The current quarter. It ranges from a high estimate of $1.12B to a low estimate of $1.09B. As of. The current estimate, Illumina Inc’s year-ago sales were $1.1BFor the next quarter, 15 analysts are estimating revenue of $1.06B. There is a high estimate of $1.09B for the next quarter, whereas the lowest estimate is $1.02B.
A total of 17 analysts have provided revenue estimates for ILMN’s current fiscal year. The highest revenue estimate was $4.31B, while the lowest revenue estimate was $4.27B, resulting in an average revenue estimate of $4.29B. In the same quarter a year ago, actual revenue was $4.37BBased on 17 analysts’ estimates, the company’s revenue will be $4.38B in the next fiscal year. The high estimate is $4.42B and the low estimate is $4.33B.
